0 24 September 2026 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 11599818 2024-01-01 2024-12-31 11599818 2024-12-31 11599818 2023-12-31 11599818 2023-03-01 2023-12-31 11599818 2023-12-31 11599818 2023-02-28 11599818 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 11599818 bus:Director8 2024-01-01 2024-12-31 11599818 core:WithinOneYear 2024-12-31 11599818 core:WithinOneYear 2023-12-31 11599818 core:ShareCapital 2024-12-31 11599818 core:ShareCapital 2023-12-31 11599818 bus:Director1 2024-01-01 2024-12-31 11599818 bus:SmallEntities 2024-01-01 2024-12-31 11599818 bus:Audited 2024-01-01 2024-12-31 11599818 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11599818 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11599818 bus:FullAccounts 2024-01-01 2024-12-31 11599818 bus:OrdinaryShareClass1 2024-12-31 11599818 bus:OrdinaryShareClass1 2023-12-31
COMPANY REGISTRATION NUMBER: 11599818
CPL New 4 Limited
Filleted Financial Statements
31 December 2024
CPL New 4 Limited
Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
Current assets
Debtors
5
34,092
367,011
Cash at bank and in hand
10,389
38,010
--------
---------
44,481
405,021
Creditors: amounts falling due within one year
6
( 44,479)
( 405,019)
--------
---------
Net current assets
2
2
----
----
Total assets less current liabilities
2
2
----
----
Net assets
2
2
----
----
Capital and reserves
Called up share capital
7
2
2
----
----
Shareholders funds
2
2
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorised for issue on 22 September 2026 , and are signed on behalf of the board by:
N J Brown
Director
Company registration number: 11599818
CPL New 4 Limited
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 1.08, 50 York Way, London, N1 9AB, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Going concern
After making enquiries, the Directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements. In establishing whether to continue to report under the going concern assumption we have considered the following points: - The impact on the day to day trade of the business - The impact on the ability of our suppliers to meet our needs - The impact of our staff's ability to perform their duties - The impact on our cash position of a period of minimum activity After considering all factors, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the accounts.
Significant estimation technique adopted
Accruals are estimated by reference to purchase orders raised at the period end and estimates to complete. Payments received on account are estimated by reference to percentage of completion of the television production, as noted in "Revenue recognition" below.
Comparatives
The accounts cover the year from 1 January 2024 to 31 December 2024. The comparatives cover the period from 1 March 2023 to December 2023.
The previous accounting period was shortened to align the company with the wider non-UK group, hence the figures are not entirely comparable.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying small entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under section 1A of FRS 102: (a) No cash flow statement has been presented for the company. (b) Disclosures in respect of financial instruments have not been presented.
Revenue recognition
Turnover relates to the production of the television series entitled "Chemistry of Death". It represents the value of the work done in the period, including estimates of amounts not invoiced and is stated after trade discounts, other taxes and net of VAT. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.
Cash and cash equivalents
Cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value, bank overdrafts, and amounts in transit from payment processors for credit card and debit card transactions.
All cash and cash equivalents are at the Company's free disposal.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
4. Employees
The company has been incorporated to produce a high-end television series called "Chemistry of Death". In common with the film and television industry the majority of crew are hired on short term contracts for the duration of principal photography or are self-employed.
None of the Directors received any form of remuneration.
5. Debtors
2024
2023
£
£
Trade debtors
–
174,250
Prepayments and accrued income
–
137,422
VAT recoverable
6,567
22,809
Other debtors
27,525
32,530
--------
---------
34,092
367,011
--------
---------
6. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
4,800
172,332
Accruals and deferred income
4,500
–
Production loan
–
230,000
Other creditors
35,179
2,687
--------
---------
44,479
405,019
--------
---------
7. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
2
2
2
2
----
----
----
----
8. Summary audit opinion
The auditor's report dated 24 September 2026 was unqualified .
The senior statutory auditor was Stephen Joberns , for and on behalf of Moore Kingston Smith LLP .
9. Related party transactions
During the year, Cuba Pictures Limited invoiced a total of £nil (2023: £138,374.20) to the company for recharged production costs and company production fee. Cuba Pictures Limited is a joint shareholder of the company. During the year, Nadcon Film GmbH invoiced a total of £nil (2023: £80,391.78) to the company for recharged production costs and company production fee. Nadcon Film GmbH is a joint shareholder of the company. All other transactions related to the production of the television series "Chemistry of Death" and arose on an arm's-length basis through the normal course of business and therefore are not required to be disclosed under FRS 102 Section 33.
10. Controlling party
During the year the company was jointly owned by Cuba Pictures Limited and Nadcon Film GmbH and hence was under no overall control. Whilst the single share was originally held by Cuba Pictures Limited the company was operated as a Joint Venture between the parties during the whole of the production of the television series.